“…Some indolequinones and their derivatives are cytotoxic to cancer cell lines which overexpress NQO1, and induce high‐level ROS (Jiho et al, 2019; Reigan et al, 2007; Sasaki et al, 2014; Xu et al, 2017). Moreover, according to structure‐activity relationship (SAR) analysis of quinone derivatives, the amino substituent on quinone ring moiety favorably impacts binding to the active site of NQO1 and ROS induction in various cancer cells (Jiho et al, 2019; Ling, Guo, et al, 2018; Ling, Yang, et al, 2018; Parkinson, Bair, Cismesia, & Hergenrother, 2013; Sasaki et al, 2014; Valderrama, Ibacache, Arancibia, Rodriguez, & Theoduloz, 2009). Many quinone analogs bearing alkyl amino substitutions have been reported to have improved antitumor activities against different tumor cell lines, however, the antitumor activities of some are modest (Kumar et al, 2019; Nishiyama et al, 2017; Parkinson & Hergenrother, 2015; Salvador et al, 2017).…”